Women’s Health

Agendia’s MammaPrint Spots Ultra-Low Breast Cancer Recurrence Risks Helping Identify Women Who Could Skip Chemo

Breast cancer test maker Agendia has released new data suggesting its MammaPrint genomic diagnostic spots breast cancer patients with ultra-low risk of recurrence, who could skip chemo and are likely to keep cancer at bay for at least 20 years. This information, culled from an analysis of 70 different genes, could help oncologists tailor treatment plans for certain early-stage breast cancer cases,…

Gynesonics’ Sonata System Is Now Covered by Cigna for the Treatment of Uterine Fibroids

Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Cigna has released a national coverage policy for treatment of uterine fibroids with the Sonata System.  The Sonata System uses radiofrequency energy to ablate fibroids under real time sonography guidance from within the uterine cavity, utilizing the first and only intrauterine ultrasound…

Auransa and POLARISqb Enter Research Collaboration to Find Treatments for Neglected Women’s Diseases Like Endometriosis and PCOS

Auransa, an artificial intelligence (AI) company developing precision medicines in areas of unmet medical needs, and Polaris Quantum Biotech (POLARISqb), a quantum drug design company, announced a research collaboration addressing therapeutics for neglected diseases disproportionately affecting women. The partnership seeks to discover treatments that may tackle many such diseases, and their complementary expertise promises to seek solutions that elude medical research.  Auransa…

Cigna Now Covers Hologic’s Acessa Procedure for Uterine Fibroids

Women’s health company Hologic has announced a new parntership with Cigna, one of the largest global health insurance service companies. Cigna has updated its medical policy to cover Hologic’s Acessa Laparoscopic Radiofrequency Ablation (Lap-RFA) procedure (CPT code 58674) as medically necessary. This new coverage further validates laparoscopic radiofrequency ablation (Lap-RFA) as a standard of care for uterine fibroids. The Acessa procedure can…

#VulvaTalk: Callaly Launches “We Need to Talk about Vulvas Campaign” to Dispel the Myth of the Perfect Vulva

Period-care brand Callaly has launched “We Need to Talk About Vulvas”, a new campaign to encourage #VulvaTalk and debunk “the myth of the perfect vulva”, centering diverse, real life experiences of people with vulvas and providing new educational material for parents, educators and people with vulvas. The campaign launches with research showing almost a third (29%) of people aged 16 to 35…

Female-founded Psychedelic Biotech Company Aphrodite Health Launches with a Focus on Women’s Mental and Physical Health

Aphrodite Health, a new biotech company in the rapidly emerging multibillion dollar psychedelic medicine sector, launches today. Founded by women, and focused on addressing women’s mental and physical health with psychedelic enhanced treatments, the company has developed a two pronged approach, with a long term drug discovery program to bring an FDA approved drug to market. Aphrodite Health is a US-based psychedelic…

Cambridge Femtech Society: An Interview with Emily Otterbeck & Lesley Farrah Dorwling-Carter, Founders of the First Femtech Society at a European University

Is student engagement in the femtech community crucial in raising awareness of the field among researchers, innovators and future entrepreneurs? Lesley Farrah Dorwling-Carter and Emily Otterbeck, two students currently enrolled in Cambridge University’s MPhil in Bioscience Enterprise Program, certainly think so! And this belief has recently led them to launching the Cambridge Femtech Society, the first official society dedicated to women’s health…

Women’s Supplement Brand Rae Closes a $9.5M Series A to Accelerate Growth and Define a New Enterprise Model for Consumer Wellness

Rae, a socially-conscious, women-led wellness brand dedicated to supporting the well-being of all, today announced the close of a $9.5 million Series A investment round led by PowerPlant Partners. PowerPlant Partners is joined by M13 and Able Partners, two existing Rae investors, and supported by initial capital investor Victress Capital. The financing provides Rae with the capital runway it needs to accelerate growth to…